Novel Approaches in Preventing or Limiting Events III | Clinical Trial - NAPLES III


Bivalirudin has been shown to be superior to unfractionated heparin (UFH) for anticoagulation in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). The current trial sought to compare outcomes between UFH and bivalirudin in patients undergoing elective PCI via the femoral approach, and who were at high-risk for bleeding.

Contribution to the Literature: In mostly elective patients undergoing PCI via the transfemoral approach, UFH had similar...